Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 1
1988 1
1989 1
1991 4
1992 3
1993 3
1994 5
1995 4
1996 6
1997 7
1998 6
1999 5
2000 7
2001 11
2002 15
2003 8
2004 13
2005 8
2006 13
2007 15
2008 21
2009 29
2010 22
2011 26
2012 20
2013 20
2014 31
2015 28
2016 28
2017 22
2018 24
2019 24
2020 26
2021 27
2022 31
2023 45
2024 35
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

518 results

Results by year

Filters applied: . Clear all
Page 1
Segmentectomy versus lobectomy in small-sized peripheral non-small-cell lung cancer (JCOG0802/WJOG4607L): a multicentre, open-label, phase 3, randomised, controlled, non-inferiority trial.
Saji H, Okada M, Tsuboi M, Nakajima R, Suzuki K, Aokage K, Aoki T, Okami J, Yoshino I, Ito H, Okumura N, Yamaguchi M, Ikeda N, Wakabayashi M, Nakamura K, Fukuda H, Nakamura S, Mitsudomi T, Watanabe SI, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Saji H, et al. Among authors: yoshino i. Lancet. 2022 Apr 23;399(10335):1607-1617. doi: 10.1016/S0140-6736(21)02333-3. Lancet. 2022. PMID: 35461558 Clinical Trial.
Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground-glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial.
Aokage K, Suzuki K, Saji H, Wakabayashi M, Kataoka T, Sekino Y, Fukuda H, Endo M, Hattori A, Mimae T, Miyoshi T, Isaka M, Yoshioka H, Nakajima R, Nakagawa K, Okami J, Ito H, Kuroda H, Tsuboi M, Okumura N, Takahama M, Ohde Y, Aoki T, Tsutani Y, Okada M, Watanabe SI; Japan Clinical Oncology Group. Aokage K, et al. Lancet Respir Med. 2023 Jun;11(6):540-549. doi: 10.1016/S2213-2600(23)00041-3. Epub 2023 Mar 6. Lancet Respir Med. 2023. PMID: 36893780 Clinical Trial.
A single-arm study of sublobar resection for ground-glass opacity dominant peripheral lung cancer.
Suzuki K, Watanabe SI, Wakabayashi M, Saji H, Aokage K, Moriya Y, Yoshino I, Tsuboi M, Nakamura S, Nakamura K, Mitsudomi T, Asamura H; West Japan Oncology Group and Japan Clinical Oncology Group. Suzuki K, et al. Among authors: yoshino i. J Thorac Cardiovasc Surg. 2022 Jan;163(1):289-301.e2. doi: 10.1016/j.jtcvs.2020.09.146. Epub 2020 Nov 12. J Thorac Cardiovasc Surg. 2022. PMID: 33487427 Free article.
Early Lung Cancer Detection.
Inage T, Nakajima T, Yoshino I, Yasufuku K. Inage T, et al. Among authors: yoshino i. Clin Chest Med. 2018 Mar;39(1):45-55. doi: 10.1016/j.ccm.2017.10.003. Epub 2017 Dec 1. Clin Chest Med. 2018. PMID: 29433724 Review.
Demographics, Safety and Quality, and Prognostic Information in Both the Seventh and Eighth Editions of the TNM Classification in 18,973 Surgical Cases of the Japanese Joint Committee of Lung Cancer Registry Database in 2010.
Okami J, Shintani Y, Okumura M, Ito H, Ohtsuka T, Toyooka S, Mori T, Watanabe SI, Date H, Yokoi K, Asamura H, Nagayasu T, Miyaoka E, Yoshino I; Japanese Joint Committee of Lung Cancer Registry. Okami J, et al. Among authors: yoshino i. J Thorac Oncol. 2019 Feb;14(2):212-222. doi: 10.1016/j.jtho.2018.10.002. Epub 2018 Oct 10. J Thorac Oncol. 2019. PMID: 30316011 Free article.
Japanese guidelines for the treatment of idiopathic pulmonary fibrosis 2023:Revised edition.
Bando M, Homma S, Date H, Kishi K, Yamauchi H, Sakamoto S, Miyamoto A, Goto Y, Nakayama T, Azuma A, Kondoh Y, Johkoh T, Nishioka Y, Fukuoka J, Miyazaki Y, Yoshino I, Suda T; Ministry of Health, Labour and Welfare, the Study Group on Diffuse Pulmonary Disorders, Scientific Research/Research on Intractable Diseases, and Japanese Respiratory Society. Bando M, et al. Among authors: yoshino i. Respir Investig. 2024 May;62(3):402-418. doi: 10.1016/j.resinv.2024.02.014. Epub 2024 Mar 14. Respir Investig. 2024. PMID: 38484504
[Robot-assisted Thoracic Surgery for Mediastinal Tumor].
Ochi T, Suzuki H, Hirai Y, Yamanaka T, Matsumoto H, Kaiho T, Inage T, Ito T, Tanaka K, Sakairi Y, Yoshino I. Ochi T, et al. Among authors: yoshino i. Kyobu Geka. 2023 Jul;76(7):512-517. Kyobu Geka. 2023. PMID: 37475093 Japanese.
Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer.
Miyoshi T, Ito H, Wakabayashi M, Hashimoto T, Sekino Y, Suzuki K, Tsuboi M, Moriya Y, Yoshino I, Isaka T, Hattori A, Mimae T, Isaka M, Maniwa T, Endo M, Yoshioka H, Nakagawa K, Nakajima R, Tsutani Y, Saji H, Okada M, Aokage K, Fukuda H, Watanabe SI. Miyoshi T, et al. Among authors: yoshino i. Eur J Cardiothorac Surg. 2023 Dec 1;64(6):ezad365. doi: 10.1093/ejcts/ezad365. Eur J Cardiothorac Surg. 2023. PMID: 37930048
Nationwide prospective registry database of patients with newly diagnosed untreated pleural mesothelioma in Japan.
Hasegawa S, Shintani Y, Takuwa T, Aoe K, Kato K, Fujimoto N, Hida Y, Morise M, Moriya Y, Morohoshi T, Suzuki H, Chida M, Endo S, Kadokura M, Okumura M, Hattori S, Date H, Yoshino I. Hasegawa S, et al. Among authors: yoshino i. Cancer Sci. 2024 Feb;115(2):507-528. doi: 10.1111/cas.16021. Epub 2023 Dec 4. Cancer Sci. 2024. PMID: 38047872 Free PMC article.
518 results